Karla Merz, PhD, is an experienced professional in business development and research with a current position as Senior Associate for Business Development External R&D at Amgen since October 2020, focusing on strategic insights and licensing opportunities. Previously, Karla served as a Postdoctoral Researcher at City of Hope, leading projects on therapeutic targets for Type 2 Diabetes, and gained recognition as lead author on high-profile publications. Karla's educational background includes a PhD in Biology from the Irell & Manella Graduate School of Biological Sciences, a certificate in Bioscience Management from Keck Graduate Institute, and a BSc in Human/Medical Genetics from UCL.